Business Standard

Concord Drugs Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of News Paper Publication.01/06/2024
Update on board meeting The Board Meeting to be held on 25/05/2024 has been revised to 30/05/2024 The Bo...Read More24/05/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More21/05/2024
Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 31.03.2024. Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More15/05/2024
For Year Ended 31.03.2024 Compliance certificate under regulation 7(3) of SEBI (LODR)30/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate Under Regulation 74(5) of SEBI (DP) Regulation 2018.15/04/2024
Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 . Certificate Under regulation 74(5) of SEBI ( Depositories and Participants) Regu...Read More15/04/2024
Closure of Trading Window Intimation of trading window closure29/03/2024
Appointment of Company Secretary and Compliance Officer Appointment of Ms. Namratha Nagla as Company Secretary Cum Compliance Officer19/03/2024
Board Meeting Outcome for Appointment Of Company Secretary Cum Compliance Officer Appointment of Ms. Namratha Nagla (ACS-68979) as Company Secretary Cum Complianc...Read More19/03/2024
Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31St December 2023. Un audited results (standalone and consolidated for the quarter ended 31.12.202313/02/2024
Board Meeting Outcome for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31* December 2023. Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended...Read More13/02/2024
Board Meeting Intimation for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023. Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More06/02/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under reg. 74(5)20/01/2024
Clarification clarification04/01/2024
Penalty Imposed By SEBI On The Company Directors Etc. Penalty imposed by SEBI on the Company Directors etc.23/08/2023
Clarification sought from Concord Drugs Ltd The Exchange has sought clarification from Concord Drugs Ltd on August 1 2023 wi...Read More01/08/2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of Loss of Certificate/Duplicate Certificate24/07/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate u/r 74(5) for the quarter ended 30.06.202321/07/2023
Closure of Trading Window Closure of Trading Window30/06/2023

Load more